Search Results 971-980 of 15333 for alt

  1. TAS-102 in Treating Advanced Biliary Tract Cancers - Mayo Clinic

    Aspartate transaminase (AST) or alanine transaminase (ALT) =< 3 x ULN; Creatinine =< 1.5 x ULN; Negative pregnancy test done =< 7 days prior to registration ...

  2. A Study Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma - Mayo Clinic

    AST/ALT ≤ 3.0 x ULN;; Creatinine < 1.5 x ULN OR Calc. Creatinine Clearance > 50 mL/min.***. *. In the absence of transfusion within the previous 24 hours ...

  3. A Study of the Effect of Ezogabine on Motor Neuron Excitability in Patients with Amyotrophic Lateral Sclerosis - Mayo Clinic

    Serum AST and ALT value >2.0 times the upper normal limit; Clinically significant conduction abnormalities on electrocardiogram or a known history of cardiac ...

  4. Cisplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery - Mayo Clinic

    ULN: ______ ALT ______ Date: ______. Serum creatinine ≤ 1.5 X institutional ULN and creatinine clearance ≥ 60 ml/min. ULN: ______ Creatinine ...

  5. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) - Mayo Clinic

    AST and ALT < 2 x upper limit of normal; Total bilirubin within normal limits. Exclusion Criteria: Patients cannot have any other form of chemotherapy for ...

  6. IFX_HU2.0 As An Adjunctive Therapy To Pembrolixumab In Checkpoint Inhibitor Naive Subjects With Advanced Or Metastatic Merkel Cell Carcinoma - Mayo Clinic

    Serum Alanine Aminotransferase (ALT) ≤ 1 - 3 x ULN; Serum Aspartate Aminotransferase (AST) ≤ 1 - 3 x ULN; Alkaline Phosphatase (ALP) ≤ 1 - 2.5 x ULN; Gamma ...

  7. Radiation Therapy With Or Without Temozolomide In Treating Patients With Low-Grade Glioma - Mayo Clinic

    AST and ALT ≤ 3 times ULN; Creatinine ≤ 2.0 times ULN; Not pregnant or nursing; Negative pregnancy test; Able to undergo MRI with and without contrast; No ...

  8. A Study to Evaluate Gemcitabine, Cisplatin, and Nab-Paclitaxel to Treat Patients with High-Risk Liver Bile Duct Cancer Before Surgery - Mayo Clinic

    AST and ALT ≤ 2.5 x ULN; and; Albumin ≥ 3 g/dl. Adequate renal function as evidenced by: Ccreatinine ≤ 1.5 x ULN. Male, or a non-pregnant and non ...

  9. Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System - Mayo Clinic

    AST and ALT < 2 times ULN for age; Shortening fraction of ≥ 27% by echocardiogram; Ejection fraction of ≥ 47% by radionuclide angiogram; No evidence of ...

  10. Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis - Mayo Clinic

    AST and ALT ≤ 5 × upper limit of normal (ULN). Exclusion Criteria: Hepatitis B surface Antigen (HBsAg) positive; Hepatitis C antibody (HCVAb) positive with ...